Željko Antić
Impact in
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 7
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Edwin Sonneveld (5 shared papers)Roland P. Kuiper (5 shared papers)Peter M. Hoogerbrugge (4 shared papers)Esmé Waanders (3 shared papers)Jiangyan Yu (3 shared papers)Frank N. van Leeuwen (3 shared papers)Simon V. van Reijmersdal (3 shared papers)Stefan H. Lelieveld (2 shared papers)
- Journals
- Best Practice & Research Clinical Haematology (2 papers)HemaSphere (1 paper)Haematologica (1 paper)Genes (1 paper)Leukemia (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Željko Antić
7 papers receiving 47 citations
Peers
Comparison fields: 5 of 13
- Hematology 22
- Public Health, Environmental and Occupational Health 33
- Cancer Research 12
- Pediatrics, Perinatology and Child Health 13
- Genetics 4
Countries citing papers authored by Željko Antić
This map shows the geographic impact of Željko Antić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Željko Antić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Željko Antić more than expected).
Fields of papers citing papers by Željko Antić
This network shows the impact of papers produced by Željko Antić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Željko Antić. The network helps show where Željko Antić may publish in the future.
Co-authors
The 25 scholars most cited alongside Željko Antić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | 2021 | 10 | |
| 3 | 2021 | 7 | |
| 4 | 2020 | 6 | |
| 5 | 2017 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2026 | 0 | |
| 9 | 2023 | 0 |
About Željko Antić
Željko Antić is a scholar working on Public Health, Environmental and Occupational Health, Cancer Research, Molecular Biology, Hematology and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 47 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Cancer Genomics and Diagnostics (5 papers), Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers), Genomics and Rare Diseases (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Epigenetics and DNA Methylation (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (22 citations), Public Health, Environmental and Occupational Health (33 citations), Cancer Research (12 citations), Pediatrics, Perinatology and Child Health (13 citations) and Genetics (4 citations). Željko Antić has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Edwin Sonneveld, Roland P. Kuiper, Peter M. Hoogerbrugge, Esmé Waanders, Jiangyan Yu, Frank N. van Leeuwen, Simon V. van Reijmersdal, Stefan H. Lelieveld, Philippe Chouvarine and Martin Schrappe. Their work appears in journals such as Best Practice & Research Clinical Haematology, HemaSphere, Haematologica, Genes and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.